Different reports provide evidence showing the participation of bromocriptine, i.e. a D2R agonist, in the down-regulation of caspase 3 activity and the induction of Bcl-2 protein expression in rat cardiomyocytes after myocardial ischemia [35, 50]. The gene discussed is BCL2; the disease is myocardial ischemia.